
Czech motor fuel prices will be capped from Wednesday, with the cap being updated daily, the Finance Ministry announced on Tuesday, against the backdrop of the energy crisis resulting from the Iran war.
The ministry has set the initial cap on the price for petrol at 43.15 koruna ($2.04) and for diesel at 49.59 koruna.
Other measures passed by the government include limiting margins charged by fuel companies and cutting the tax on diesel.
The ministry said the aim of the measures was to curb general fuel price rises and to remove local pricing extremes. The last was seen as referring to Prague and motorway fuel stations, where the highest prices are generally charged.
The country is well served with fuel stations operated by Poland's Orlen, Hungary's MOL, and state-run Cepro under its Eurooil and Robin Oil brands.
Relatively low prices have led German drivers to cross the border to fill up.
latest_posts
- 1
The most effective method to Guarantee Thorough Inclusion in Senior Protection. - 2
Senegal limits foreign trips for officials as the fallout from Iran war deepens - 3
Iranian strikes on Israel injure 11 and set chemical plant ablaze - 4
Novartis to build manufacturing hub in North Carolina, creating 700 jobs - 5
Soldiers seize power in Guinea-Bissau and detain the president
Why doing good also makes us feel good, during the holidays and beyond
Human evolution’s biggest mystery has started to unravel. How 2025 tipped the scales
Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
Women take pride in Holy Week roles after a Spanish Catholic brotherhood's procession excluded them
I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.
'Spending more on gas than groceries:' Rising fuel prices drive more San Antonio families to the Food Bank amid Iran war
Industrial zone damaged in Negev, falls in Sharon area after Iran fires missiles towards Israel
Massachusetts court hears arguments in lawsuit alleging Meta designed apps to be addictive to kids
US FDA declines to approve Corcept's drug for rare hormonal disorder











